Singapore Clinical Trial: A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Firmonertinib Compared with Investigator’s Choice of Osimertinib or Afatinib as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations (ALPACCA)

Singapore, July 16 -- The Health Sciences Authority received information related to the study titled 'A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety o... Read More

Singapore Clinical Trial: A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MK-2214 in Participants with Early Alzheimer's Disease

Singapore, July 16 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Effic... Read More

Singapore Clinical Trial: Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascending Dose Portion and a Phase 2 Open-Label Portion, to Evaluate the Safety and Efficacy of Oral Infigratinib in Infants and Young Children with Achondroplasia

Singapore, July 16 -- The Health Sciences Authority received information related to the study titled 'Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascend... Read More

Singapore Clinical Trial: A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer Following Recurrence or Progression On or After Treatment with a CDK4/6 Inhibitor

Singapore, July 16 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant ... Read More

Singapore Clinical Trial: A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway inflammation through assessments of mucus plugging and other lung imaging parameters in patients with chronic obstructive pulmonary disease

Singapore, July 16 -- The Health Sciences Authority received information related to the study titled 'A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway... Read More

TSMC Posts 77% Profit Surge and Pledges $100 Billion More for US Chip Manufacturing

New Delhi, July 16 -- TAIPEI - TSMC CEO Che-Chia Wei told analysts Thursday that AI chip demand is "extremely robust" and expected to remain "very strong until around 2029 or 2030." That is not a fore... Read More

Delivery Hero Backs Uber's €13 Billion Takeover, Creating 99-Country Food Empire

New Delhi, July 16 -- BERLIN - The board of Delivery Hero formally endorsed Uber's €13 billion takeover offer Thursday at €41.50 per share in cash, and Prosus, the Dutch investment company... Read More

Canadian Wildfire Smoke Triggers Air Quality Alerts Across 20 US States

New Delhi, July 16 -- a classification that health agencies describe as unsafe for everyone, with no exceptions for healthy adults or outdoor workers. The smoke came from Canada, carried south by wind... Read More

Italian Court Convicts 32 Over Genoa Bridge Collapse That Killed 43

New Delhi, July 16 -- GENOA - Egle Possetti was in the courtroom on Thursday as Judge Paolo Lepri began reading sentences, eight years of proceedings reduced to each name called. She had lost her sist... Read More

Patna murder case: Primary accused injured in encounter with police

India, July 16 -- The main accused in the abduction and murder of a grocery owner was injured in a police encounter in Patna, officials said on Thursday. The injured, identified as Ravish Kumar alias ... Read More

• ««
• «
• 11437
• 11438
• 11439
• 11440
• 11441
• 11442
• 11443
• 11444
• 11445
• 11446
• »
• »»